<p><a href="http://us.rd.yahoo.com/dailynews/rss/business/*http://news.yahoo.com/s/nm/20051209/bs_nm/vioxx_journal_dc"><img src="http://us.news3.yimg.com/us.i2.yimg.com/p/nm/20051209/2005_12_08t162253_317x450_us_vioxx_journal.jpg?x=9 1&amp;y=130&amp;sig=eoYlBLEcgYK8coTAZ2g22A--" align="left" height="130" width="91" alt="A bottle of prescription arthritis and pain medication Vioxx is seen on a shelf at a New York City Pharmacy in this file photo taken on September 30, 2004. The New England Journal of Medicine on Thursday said Merck and Co. withheld information about the cardiac side effects of arthritis drug Vioxx when it presented the journal data from a key trial on the medicine's safety in 2000. (Mike Segar/Reuters)" border="0" /></a>Reuters - A prestigious medical journal on
Thursday said Merck &amp; Co. withheld information about the
dangers of arthritis drug Vioxx in a key study, an alleged
lapse that analysts said could hurt Merck as it defends itself
against Vioxx-related lawsuits.</p><br clear=all>

View the entire article: Merck deleted Vioxx safety info: Journal (Reuters)